Free Trial
LON:CEL

Celadon Pharmaceuticals (CEL) Share Price, News & Analysis

Celadon Pharmaceuticals logo
GBX 13.80 -1.70 (-10.97%)
(As of 08:35 AM ET)

About Celadon Pharmaceuticals Stock (LON:CEL)

Key Stats

Today's Range
12.10
16.30
50-Day Range
15.50
38
52-Week Range
12.10
130
Volume
315,651 shs
Average Volume
79,888 shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Receive CEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CEL Stock News Headlines

Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Celadon Pharmaceuticals Plc (CEL.L)
See More Headlines

CEL Stock Analysis - Frequently Asked Questions

Celadon Pharmaceuticals' stock was trading at GBX 115 at the beginning of the year. Since then, CEL stock has decreased by 88.8% and is now trading at GBX 12.86.
View the best growth stocks for 2024 here
.

Shares of CEL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celadon Pharmaceuticals investors own include AutoZone (AZO), Bahamas Petroleum (BPC), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM) and Avino Silver & Gold Mines (ASM).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
CIK
N/A
Fax
N/A
Employees
2,780
Year Founded
N/A

Profitability

Net Income
£-5,230,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£11,258.00
Cash Flow
GBX 3.95 per share
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£8.30 million
Optionable
Not Optionable
Beta
-0.26
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:CEL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners